[1] 沙益辉,谢雁鸣,王连心,等.真实世界35 984例肝硬化患者临床特征探析.中华中医药杂志,2016,31:2087-2090.
[2] 张伟,贾继东.肝纤维化的发病机制及治疗新靶点.临床肝胆病杂志,2017,33:409-412.
[3] 林秀梅,朱冬林,陈文思.肝纤维化四项检查与天冬氨酸氨基转移酶和血小板比率联合检测在诊断慢性乙型肝炎纤维化中的意义.中国卫生检验杂志,2017,27:1136-1142.
[4] Hashemi SA, Alavian SM, Gholami-Fesharaki M. Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis . CaspianJ InternMed, 2016, 7: 242-252.
[5] Bugaev N, Breeze JL, Daoud V, et al. Management and outcome of patients with blunt splenic injury and preexisting liver cirrhosis . J Trauma Acute Care Surg, 2014, 76: 1354-1361.
[6] 张清清,陆伦根.乙型肝炎及丙型肝炎肝纤维化、肝硬化的诊断与治疗.肝脏,2014,19:368-370.
[7] Lewin M, Poujol-Robert A, Boëlle PY, et al. Diffusion-weighted magnetic resonance imaging for the assessment of the fibrosis in chronic hepatitis . Hepatology, 2007, 46: 658-665.
[8] Bachofner JA, Valli PV, Kröger A, et al. Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index . Liver International, 2017, 37: 369.
[9] Fallatah HI, Akbar HO, Fallatah AM. Fibroscan compared to FIB-4, APRI, and AST/ALT ratio for Assessment of liver fibrosis in Saudi patients with nonalcoholic fatty liver disease . Hepat Mon, 2016, 16: e38346.
[10] 谢琴秀,徐楠,江晓平,等.FibroScan对慢性乙型肝炎病毒感染者肝纤维化评估的影响因素分析.中华肝脏病杂志,2016,24:659-664.
[11] 孙树申,向慧玲,刘芳,等.瞬时弹性成像技术对慢性肝病患者肝硬化程度及食管胃底静脉曲张破裂出血的预测研究.中国全科医学,2015,18:4147- 4152.
[12] Lim JK, Flamm SL, Singh S, et al. American Gastro-enterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis. Gastroenterology, 2017, 152: 1536. |
